| scholarly article | Q13442814 |
| P50 | author | John Julian Fung | Q61476062 |
| P2093 | author name string | S Zhang | |
| A Jain | |||
| R Venkataramanan | |||
| J Lever | |||
| V S Warty | |||
| S Zuckerman | |||
| I S Hamad | |||
| P2860 | cites work | The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients | Q28377146 |
| Randomised trialomania? The multicentre liver transplant trials of tacrolimus | Q34289636 | ||
| Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression | Q44652391 | ||
| Pharmacokinetics of oral mycophenolate mofetil in volunteer subjects with varying degrees of hepatic oxidative impairment | Q46111550 | ||
| Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration | Q46363542 | ||
| Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. | Q52312810 | ||
| A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation | Q54022204 | ||
| RS-61443--a phase I clinical trial and pilot rescue study | Q67513704 | ||
| Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy | Q73278022 | ||
| Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function | Q74458881 | ||
| Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure | Q74535269 | ||
| The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function | Q74662793 | ||
| The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation | Q77743596 | ||
| P433 | issue | 3 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 268-276 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | The Journal of Clinical Pharmacology | Q7743562 |
| P1476 | title | Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus | |
| P478 | volume | 41 |
| Q38489448 | A clinical assessment of mycophenolate drug monitoring after liver transplantation |
| Q33602527 | A comprehensive review of immunosuppression used for liver transplantation |
| Q34346290 | Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management |
| Q38242804 | Clinical mycophenolic acid monitoring in liver transplant recipients |
| Q34573738 | Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients |
| Q38438816 | Correlation between mycophenolic acid blood level and renal dysfunction in stable liver transplant recipients receiving mycophenolate monotherapy |
| Q39729251 | Correlation between pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients |
| Q46961396 | Development of a CE method for the determination of mycophenolic acid in human plasma: a comparison with HPLC. |
| Q36133776 | Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil |
| Q42918739 | Establishment of High-Performance Liquid Chromatography and Enzyme Multiplied Immunoassay Technology Methods for Determination of Free Mycophenolic Acid and Its Application in Chinese Liver Transplant Recipients |
| Q37355472 | Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients |
| Q44328108 | High-performance liquid chromatographic method for mycophenolic acid and its glucuronide in serum and urine |
| Q87605948 | Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy |
| Q45188818 | Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients |
| Q46495046 | Measurement of mycophenolic acid in plasma or serum by a commercial enzyme inhibition technique in comparison with a high performance liquid chromatography method |
| Q46606996 | Mycophenolate mofetil in islet cell transplant: variable pharmacokinetics but good correlation between total and unbound concentrations |
| Q36544988 | Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability |
| Q37859983 | Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report. |
| Q35129548 | Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies |
| Q36006086 | Pharmacokinetic principles of immunosuppressive drugs. |
| Q38711186 | Pharmacokinetics of drugs in adult living donor liver transplant patients: regulatory factors and observations based on studies in animals and humans |
| Q51924523 | Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients. |
| Q46623389 | Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients |
| Q38485971 | Pharmacokinetics of mycophenolic acid in living donor liver transplantation. |
| Q46847080 | Pharmacokinetics of oral mycophenolate mofetil in combination with CsA in dogs after nonmyeloablative allogeneic hematopoietic stem cell transplantation |
| Q83171464 | Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen |
| Q36336060 | Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children. |
| Q34180482 | Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantation |
| Q33394798 | Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study |
| Q46006952 | Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off level. |
| Q51456595 | Simultaneous determination of mycophenolate and its metabolite mycophenolate-7-o-glucuronide with an isocratic HPLC-UV-based method in human plasma and stability evaluation. |
| Q35574966 | The use of mycophenolate mofetil in liver transplant recipients |
| Q43166785 | Variability in free mycophenolic acid exposure in adult liver transplant recipients during the early posttransplantation period |
Search more.